MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 134 filers reported holding MACROGENICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,127,900 | -12.3% | 6,036,030 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $32,080,933 | -25.4% | 5,996,436 | -0.0% | 0.00% | 0.0% |
| Q1 2023 | $42,996,919 | +7.0% | 5,996,781 | +0.1% | 0.00% | 0.0% |
| Q4 2022 | $40,196,291 | +103.0% | 5,990,505 | +4.7% | 0.00% | 0.0% |
| Q3 2022 | $19,801,000 | +25.4% | 5,722,945 | +7.0% | 0.00% | 0.0% |
| Q2 2022 | $15,786,000 | -65.3% | 5,350,804 | +3.6% | 0.00% | 0.0% |
| Q1 2022 | $45,521,000 | -45.4% | 5,166,900 | -0.5% | 0.00% | -50.0% |
| Q4 2021 | $83,377,000 | -25.8% | 5,194,833 | -3.1% | 0.00% | -33.3% |
| Q3 2021 | $112,299,000 | -24.9% | 5,362,806 | -3.7% | 0.00% | -25.0% |
| Q2 2021 | $149,589,000 | -18.8% | 5,569,197 | -3.7% | 0.00% | -20.0% |
| Q1 2021 | $184,207,000 | +57.9% | 5,783,605 | +13.3% | 0.01% | +25.0% |
| Q4 2020 | $116,697,000 | -3.1% | 5,104,831 | +6.8% | 0.00% | 0.0% |
| Q3 2020 | $120,449,000 | -3.6% | 4,781,591 | +6.8% | 0.00% | -20.0% |
| Q2 2020 | $125,009,000 | +349.8% | 4,477,385 | -6.2% | 0.01% | +400.0% |
| Q1 2020 | $27,792,000 | -45.9% | 4,775,157 | +1.1% | 0.00% | -50.0% |
| Q4 2019 | $51,380,000 | -12.7% | 4,722,537 | +2.4% | 0.00% | 0.0% |
| Q3 2019 | $58,837,000 | -21.2% | 4,610,978 | +4.8% | 0.00% | -33.3% |
| Q2 2019 | $74,662,000 | +22.0% | 4,399,564 | +29.2% | 0.00% | 0.0% |
| Q1 2019 | $61,218,000 | +41.7% | 3,404,692 | +0.1% | 0.00% | +50.0% |
| Q4 2018 | $43,198,000 | -37.5% | 3,401,391 | +5.5% | 0.00% | -33.3% |
| Q3 2018 | $69,150,000 | +7.3% | 3,225,256 | +3.3% | 0.00% | 0.0% |
| Q2 2018 | $64,472,000 | -3.5% | 3,122,067 | +17.5% | 0.00% | 0.0% |
| Q1 2018 | $66,828,000 | +32.6% | 2,656,119 | +0.1% | 0.00% | +50.0% |
| Q4 2017 | $50,409,000 | +1.2% | 2,653,178 | -1.5% | 0.00% | -33.3% |
| Q3 2017 | $49,802,000 | +9.3% | 2,694,891 | +3.5% | 0.00% | +50.0% |
| Q2 2017 | $45,577,000 | -1.0% | 2,602,987 | +5.1% | 0.00% | -33.3% |
| Q1 2017 | $46,055,000 | +90203.9% | 2,476,065 | +98823.9% | 0.00% | – |
| Q4 2016 | $51,000 | -41.4% | 2,503 | -14.0% | 0.00% | – |
| Q3 2016 | $87,000 | +19.2% | 2,910 | +7.8% | 0.00% | – |
| Q2 2016 | $73,000 | +97.3% | 2,699 | +36.9% | 0.00% | – |
| Q1 2016 | $37,000 | +8.8% | 1,972 | +76.4% | 0.00% | – |
| Q4 2015 | $34,000 | +161.5% | 1,118 | +77.7% | 0.00% | – |
| Q3 2015 | $13,000 | -45.8% | 629 | 0.0% | 0.00% | – |
| Q2 2015 | $24,000 | +60.0% | 629 | +34.7% | 0.00% | – |
| Q1 2015 | $15,000 | -6.2% | 467 | 0.0% | 0.00% | – |
| Q4 2014 | $16,000 | +60.0% | 467 | 0.0% | 0.00% | – |
| Q3 2014 | $10,000 | 0.0% | 467 | 0.0% | 0.00% | – |
| Q2 2014 | $10,000 | +150.0% | 467 | +191.9% | 0.00% | – |
| Q1 2014 | $4,000 | – | 160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |